Angion Biomedica Corp. (ANGN)
NASDAQ: ANGN
· Real-Time Price · USD
1.00
0.00 (0.00%)
At close: Jun 01, 2023, 10:00 PM
Angion Biomedica Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -60.26M | -49.05M | -17.12M | -29.1M | -38.81M | -17.48M | -24.19M | -32.13M | -54.57M | -98.34M | -100.3M | -103.57M |
Depreciation & Amortization | 1.17M | 896K | 297K | 811K | 991K | 973K | 900K | 874K | 801K | 724K | 648K | 612K |
Stock-Based Compensation | 2.49M | 1.97M | 327K | 1.21M | 885K | 2.69M | 5.64M | 6.96M | 12.04M | 11.18M | 10.62M | 9M |
Other Working Capital | 246K | 246K | 1.66M | -49K | -2.18M | -28.67M | -30.27M | -26.75M | -25.1M | -61.83M | -49.78M | -72.32M |
Other Non-Cash Items | 14.35M | 14.35M | 5.78M | 3.46M | 2.77M | -374K | -503K | -1.4M | 15.06M | 29.91M | 37.83M | 41.64M |
Deferred Income Tax | 16K | 16K | 16K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 9.36M | 9.36M | 4.39M | -7.19M | -4.23M | -34.14M | -36.96M | -30.05M | -25.97M | 38.83M | 26.77M | 25.61M |
Operating Cash Flow | -32.58M | -22.46M | -6.31M | -30.82M | -38.39M | -48.33M | -55.12M | -55.74M | -52.64M | -17.69M | -24.43M | -26.71M |
Capital Expenditures | -129K | -129K | -42K | n/a | n/a | -36K | -97K | -341K | -382K | -356K | -296K | -62K |
Cash Acquisitions | -3K | -3K | -3K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 10.01M | 10.01M | 3K | -10M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 9.87M | 9.87M | -42K | -10M | n/a | -36K | -97K | -341K | -382K | -356K | -296K | -62K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -36K | -36K | -36K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 65.78M | 64.59M | 21.66M | -3.31M | -60K | 359K | 1.07M | -1.29M | 107.17M | 106.97M | 137.49M | 156.92M |
Financial Cash Flow | 80.02M | 69.69M | 24.07M | -3.31M | -60K | 359K | 1.07M | -1.29M | 107.17M | 106.97M | 137.49M | 156.92M |
Net Cash Flow | 5.33M | 5.09M | 14.82M | -43.78M | -38.27M | -47.59M | -53.94M | -57.45M | 54.15M | 88.63M | 112.27M | 129.47M |
Free Cash Flow | -32.71M | -22.59M | -6.35M | -30.82M | -38.39M | -48.36M | -55.22M | -56.09M | -53.02M | -18.05M | -24.73M | -26.77M |